Clinical Trials for Cetuximab

6 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentECOGTHNR1216
01/10/2014
Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck
TreatmentVICCTHN1340
10/14/2013
A Phase II Study of Carboplatin, Nab-Paclitaxel and Cetuximab for Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
TreatmentECOGTHNR1016
09/25/2012
Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer
TreatmentECOGTHNR0920
09/12/2012
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
TreatmentVICCMD1188
06/08/2012
An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
TreatmentECOGTHO4508-M
12/07/2010
Three-Arm Randomized Phase II Study of Carboplatin and Paclitaxel in Combination with Cetuximab, IMC-A12 or Both for Advanced Non-small Cell Lung Cancer Patients WhoWill Not Receive Bevacizumab-based Therapy

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.